Melasma: Measure of the impact on quality of life using the French version of MELASQOL after cross-cultural adaptation

Acta Dermato-Venereologica

Volumn 90, Issue 3, 2010, Pages 331-332

  Misery, Laurent ^a,b   Schmitt, Anne Marie ^c   Boussetta, Sami ^d   Rahhali, Nora ^d   Taieb, Charles ^d  

^a BREST UNIVERSITY HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^c INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^d Centre d'Immunologie Pierre Fabre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADULT; CHLOASMA; CLINICAL ARTICLE; CORRELATION ANALYSIS; CULTURAL FACTOR; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RACISM; SOCIAL PSYCHOLOGY;

EID: 77953428974     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0837     Document Type: Letter

References (14)

1. Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003; 149: 572-577.
2. Kimbrough-Green CK, Griffiths CE, Finkel EJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-733.
3. Dominguez AR, Balkrishnan R, Elizey AR, Pandya AG. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language. J Am Acad Dermatol 2006; 55: 59-66.
4. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-1432.
5. Guillemin F. Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol 1995; 24: 61-63.
6. Hendricson WD, Russell J, Prihoda TJ, Jacobson JM, Rogan A, Bishop GD. An apporach to developing a valid Spanish language translation of a health-status questionnaire. Med Care 1989; 27: 959-966.
7. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-1178.
8. Ware J, Kosinski M, Keller S. A 12-item short-form health survey. Construction of sclaes and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
9. Murray WJ. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
10. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
11. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
12. Consoli SM, Taine P, Szabason F, Lacour C, Metra PC. Elaboration et validation d'un questionnaire de stress perçu proposé comme indicateur de suivi en médecine du travail. Encephale 1997; 23: 184-193.
13. Cestari TF, Hexsel D, Viegas ML, Azulay L, Hassun K, Almeida AR, et al. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQol-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol 2006; 156: 13-20.
14. Dogramaci AC, Havlucu DY, Inandi T, Balkrishnan R. Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study. J Dermatolog Treat 2009; 20: 95-99.